Fideicomiso Irrevocable F/2061 Fhipo
BNZIF
$0.46
-$0.08-15.03%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | 42.74M | 46.44M | 48.41M | 50.18M | 63.38M |
| Total Revenue | 42.74M | 46.44M | 48.41M | 50.18M | 63.38M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 42.74M | 46.44M | 48.41M | 50.18M | 63.38M |
| SG&A Expenses | 21.07M | 21.82M | 22.87M | 23.43M | 23.22M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 17.78M | 6.33M | 1.29M | -1.27M | 2.73M |
| Total Operating Expenses | 38.85M | 28.14M | 24.16M | 22.16M | 25.95M |
| Operating Income | 3.89M | 18.29M | 24.25M | 28.02M | 37.43M |
| Income Before Tax | 4.51M | 18.91M | 24.87M | 28.64M | 37.53M |
| Income Tax Expenses | 7.60K | -50.80K | -49.60K | 16.20K | 116.80K |
| Earnings from Continuing Operations | 4.51 | 18.96 | 24.92 | 28.63 | 37.42 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 4.51M | 18.96M | 24.92M | 28.63M | 37.42M |
| EBIT | -- | -- | -- | -- | -- |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.01 | 0.06 | 0.09 | 0.12 | 0.19 |
| Normalized Basic EPS | 0.00 | 0.03 | 0.05 | 0.08 | 0.12 |
| EPS Diluted | 0.01 | 0.06 | 0.09 | 0.12 | 0.19 |
| Normalized Diluted EPS | 0.00 | 0.03 | 0.05 | 0.08 | 0.12 |
| Average Basic Shares Outstanding | 1.12B | 973.89M | 830.50M | 1.06B | 838.66M |
| Average Diluted Shares Outstanding | 1.49B | 1.35B | 1.20B | 1.06B | 838.66M |
| Dividend Per Share | 0.04 | 0.07 | 0.07 | 0.07 | 0.09 |
| Payout Ratio | 544.43% | 130.12% | 103.60% | 120.75% | 109.62% |